Clinical trial
Olmesartan Medoxomil in Diabetes Mellitus
NCT00185159 · Sankyo Pharma Gmbh, Industry · Completed
Key facts
| NCT number | NCT00185159 |
|---|---|
| Title | Olmesartan Medoxomil in Diabetes Mellitus |
| Official title | Randomized Olmesartan and Diabetes Microalbuminuria Prevention Study (ROADMAP) |
| Lead sponsor | Sankyo Pharma Gmbh, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2, Cardiovascular Disease, Kidney Disease |
| Intervention type | Drug |
| Interventions | Olmesartan medoxomil, Placebo Tablets |
| Enrollment | 4,449 |
| Start date | Oct 1, 2004 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 20, 2010 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: